Join us for a free webinar on Monday, 16 October at 05:00 PM CEST about Fred X CLINICAL EVIDENCE: FIRST EUROPEAN EXPERIENCES.
Speakers of the webinar are Markus A. Möhlenbruch, MD (Heidelberg, Germany), Leopoldo Guimaraens, MD (Sant Cugat del Vallès, Spain) and Aaron Baldwin, PhD (R&D Director at MicroVention). Moderator of the webinar is Jacques Dion, MD (Vice President Scientific Affairs at MicroVention).
The webinar is supported by MicroVention and registration for the webinar is free.
What is the webinar about?
In this webinar we will highlight X technology Mechanism of action and how the proprietary surface treatment is improving FRED performance.
Key message
FRED X is showing safety and efficacy at 1Y FU.
Learning objectives
- X mechanism of action: reduce material thrombogenicity and maintain natural healing response
- More than 200 patients with 1Y FU
- Same safety and efficacy of bare FRED
About the speakers & moderator
Prof. Markus A. Möhlenbruch
Markus A. Möhlenbruch is the Head of Interventional Neuroradiology (MINTZ) at the Heidelberg University Hospital in Germany. Prof. Möhlenbruch has published more than 230 peer-reviewed papers. His practice and research has been centered on the treatment of intracranial aneurysm, cerebrovascular malformations and ischemic stroke. He has been an investigator on several stroke and aneurysm trials.
Leopoldo Guimaraens, MD
Leopoldo Guimaraens is a specialist in Neuroradiology with more than 30y of experience. He is currently head of the Diagnostic and Therapeutic Neuroangiography Service of the General Hospital of Catalonia. He has developed his healthcare activity as Head of Service in prestigious national and international hospitals. He is an active member of the French, Spanish and European Society of Neuroradiology and has published more than 120 papers and articles in books on Interventional Neuroradiology.
Aaron Baldwin, PhD
Aaron Baldwin is R&D Director at Microvention leading Laser Cut Technology and Chemistry. He actively drove the functionalization of the X polymer (Terumo) in Neurovascular devices.
Jacques Dion, MD
Jacques Dion is Vice President Scientific Affairs at MicroVention. Jacques had an extensive experience as neuroradiologist in Atlanta; after 20y of medical practice he joined MV to support future product research and give his advice and support young and experienced fellows.
What to expect?
ESMINT webinars provide you with the opportunity to meet experts, who share their experience, practice, and way of thinking regarding everyday challenges in the field of neurointerventions.
This webinar will be an interactive live transmission. All participants will be able to ask questions in real-time via the online chat.
Registered participants will be able to watch the recording afterwards.